A novel drug to reduce tumor perfusion: Antitumor effect alone and with hyperthermia

Radiation Research

Volumn 154, Issue 2, 2000, Pages 202-207

  Griffin, Robert J ^a   Ogawa, Atsushi ^a   Song, Chang W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(DIHYDROXYCYCLOPENTANYL)OXY] 2 (1 PIPERAZINYL)QUINAZOLINE; KB R 8498; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOMA; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INFUSION; HYPERTHERMIA; NONHUMAN; OSMOTIC MINIPUMP; PH MEASUREMENT; PRIORITY JOURNAL;

ANIMALIA; OXY;

EID: 0033853874     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)154[0202:ANDTRT]2.0.CO;2     Document Type: Conference Paper

References (21)

1. W. H. Knapp, H. Debatin, K. Layer, F. Helus, A. Altmann, H-J. Sinn and H. Ostertag, Selective drug-induced reduction of blood flow in tumor transplants. Int. J. Radiat. Oncol. Biol. Phys. 11, 1357-1366 (1985).
2. C. W. Song, Role of blood flow in hyperthermia. In Hyperthermia and Oncology, Vol. 3 (M. Urano and E. B. Douple, Eds.), pp. 275-315. VSP Publishers, Utrecht, 1991.
3. H. S. Reinhold and B. Endrich, Tumour microcirculation as a target for hyperthermia. Int. J. Hyperthermia 2, 111-137 (1986).
4. S. Shrivastav, W. T. Joines and R. L. Jirtle, Effect of 5-hydroxytryptamine on tissue blood flow and microwave heating of rat tumors. Cancer Res. 45, 3203-3208 (1985).
5. D. J. Chaplin, Potentiation of RSU-1069 tumour cytotoxicity by 5 hydroxytryptamine (5-HT). Br. J. Cancer 54, 727-731 (1986).
6. C. W. Song, J. C. Lyons, C. M. Makepeace, R. J. Griffin and E. J. Cragoe, Jr., Effects of HMA, an analog of amiloride, on the thermosensitivity of tumors in vivo. Int. J. Radiat. Oncol. Biol. Phys. 30, 133-139 (1994).
7. L. E. Gerweck, W. K. Dahlberg and B. Greco, Effects of pH on single or fractionated heat treatment at 42°-45°C. Cancer Res. 43, 1163-1167 (1983).
8. M. R. Molla, K. Yoshiga and K. Takada, Influence of methoxamine, 5-hydroxytryptamine and physically induced low pH on thermal sensitivity and thermotolerance. Neoplasma 34, 397-407 (1987).
9. C. W. Song, Modification of blood flow. In Medical Radiology, Diagnostic Imaging and Radiation Oncology (M. Molls and P. Vaupel, Eds.), pp. 193-207. Springer-Verlag, Heidelberg, 1997.
10. D. B. Cater, C. M. B. Grigson and D. A. Watkinson, Changes of oxygen tension in tumors induced by vasoconstriction and vasodilator drugs. Acta Radiol. 58, 401-435 (1962).
11. W. Huhnt and A. S. Lubbe, Venules and arterioles in xenotransplanted human colon adenocarcinoma critically constrict with hyperthermia and serotonin. J. Cancer Res. Clin. Oncol. 121, 267-274 (1995).
12. A. S. Lubbe and W. Huhnt, Microvessel diameters of human colon adenocarcinoma during acute treatment with serotonin. Int. J. Microcirc. Clin. Exp. 14, 218-225 (1994).
13. 2: Dependence on thermal dose and tumor type. Radiat. Res. 149, 294-299 (1998).
14. L. A. Sapirstein, Regional blood flow by fractional distribution of indicators. Am. J. Physiol. 193, 161-168 (1958).
15. 2, and cell survival in tumors. Cancer Res. 53, 2076-2080 (1993).
16. 2 agonists by tumour-feeding arterioles in mice: consequences for tumour growth. Int. J. Radiat. Biol. 60, 237-241 (1991).
17. E. Laemmel, O. Stucker, P-L. Darmon and E. Vicaut, Characterization of the specific response to serotonin of mouse tumour-feeding arterioles. Int. J. Radiat. Biol. 74, 379-386 (1998).
18. R. J. Griffin, A. Ogawa, A. Shakil and C. W. Song, Local hyperthermic treatment of solid tumors; Interplay between thermal dose and physiological parameters. In Advances in Heat and Mass Transfer in Biotechnology (S. Klegg, Ed.), pp. 67-69. HTD-362/BED-40, American Society of Mechanical Engineering, New York, 1998.
19. A. Shakil, A. Ogawa, R. J. Griffin and C. W. Song, Reduction of tumour blood flow with KB-R8498 potentiates the response of tumours to hyperthermia. Int. J. Hyperthermia 15, 1-6 (1999).
20. D. S. Houston and P. M. Vanhoutte, Serotonin and the vascular system, role in health and disease, and implications for therapy. Drugs 31, 149-163 (1986).
21. M. Abdul, P. E. Anezinis, C. J. Logothetis and N. M. Hoosein, Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res. 14, 1215-1220 (1994).